Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | RNA-Interference | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | plasmid | cotransfection (plasmid/siRNA) | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | M. Nabissi et al., Carcinogenesis, May 2010; 31: 794 - 803 | Link | |||
MZC |
Human primary glioblastoma cells | Human | brain | primary cell | siRNA | cotransfection (plasmid/siRNA) | Metafectene EASY | publication | M. Nabissi et al., Carcinogenesis, Jan 2013; 34: 48 - 57 | Link | |||
Mouse DRG neurons |
Mouse neurons collected from all spinal cord levels of Swiss Webster male mice | Mouse | nervous system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | K. M. Salerno et al., Neuroscience, 2013, 231: 28–37, doi:10.1016/j.neuroscience.2012.11.034. | Link | ||
Mouse DRG neurons |
Mouse primary dorsal root ganglia neurons | Mouse | nervous system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | X. X. Chi et al., J. Cell Sci., Dec 2009; 122: 4351 - 4362 | Link | ||
Mouse DRG neurons |
Mouse peripheral dorsal root ganglia neurons | Mouse | nervous system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | X. Jing et al., Exp. Neurol., 2012, 233 (1): 221–232, doi:10.1016/j.expneurol.2011.10.005 | Link | ||
Mouse DRG neurons |
Mouse primary sensory neurons | Mouse | nervous system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
mMSC |
Mouse bone marrow-derived mesenchymal stromal cells | Mouse | bone | primary cell | adherent | virus | viral transduction | K2 Transfection System | publication | M. Dumitrescu et al., Int. J. Mol. Sci. 2021, 22, 598, https://doi.org/10.3390/ijms22020598 | |||
mMSC |
Mouse bone marrow-derived mesenchymal stromal cells | Mouse | bone | primary cell | adherent | virus | viral transduction | K2 Transfection System | application note | ![]() |
|||
MEF |
Mouse primary embryonic fibroblasts | Mouse | unknown | primary cell | adherent | plasmid | Metafectene | application note | ![]() |
||||
mDC |
Mouse dentritic cell line | Mouse | immune system | primary cell | adherent | iron oxide | Imaging | Metafectene | publication | E. Küstermann et al., Contrast Media Mol. Imaging, 2008, 3: 27–37 | |||
mBMDM |
Mouse bone marrow derived macrophages | Mouse | immune system | primary cell | plasmid | K2 Transfection System | publication | C. A. Nold-Petry et al., Nature Immunology, 2015, 16 (4): 354, doi:10.1038/ni.310 | |||||
L1–L6 DRG |
Mouse lumbar dorsal root ganglia (DRG) | Mouse | nervous system | primary cell | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | C. Bavassano et al., Biochim. et Biophysica Acta, 2013, 1833: 3166–3175, doi.org/10.1016/j.bbamcr.2013.09.001 | Link | ||
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | siRNA | RNA-Interference | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
IMR-90 |
Human primary lung fibroblasts | ATCC CCL-186 | Human | respiratory system | primary cell | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | A. M. Szekely et al., Mol. Cell. Biol., Dec 2005; 25: 10492 - 10506 | Link | |
iDC |
Human immature dentritic cells | Human | immune system | primary cell | plasmid | Metafectene | publication | Z. K. Nazarkina et al., Mol. Biology, 2018, 52(2): 222–231, DOI: 10.1134/S0026893317050132 | |||||
hVSMC |
Human primary vascular smooth muscle cells | Human | vasculature | primary cell | adherent | plasmid | stable transfection | Metafectene | publication | G. Weisinger et al., Exp. Cell Res., 2013, 319: 1586-1593, doi.org/10.1016/j.yexcr.2013.04.001 | |||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | J. Yang et al., Oncology Reports, 2015, 34: 2745-2751; DOI: 10.3892/or.2015.4223 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050e2057 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Park et al., Biochem. and Biophys. Res. Commun., 2018, 495: 2050-2057, doi.org/10.1016/j.bbrc.2017.08.023 | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S.-W. Lee et al., Molecular Therapy, 2013, 21 (9): 1767–1777, doi:10.1038/mt.2013.146 | Link | ||
HUVEC |
Human primary umbilical vein endothelial cells | ATCC CRL-1730 | Human | vasculature | primary cell | adherent | plasmid | Metafectene PRO | publication | S. Zografou et al., J. Cell Sci., Oct 2012; 125: 4780 - 4790 | Link |